Literature DB >> 22890791

Converse regulation of CCR7-driven human dendritic cell migration by prostaglandin E₂ and liver X receptor activation.

Markus Bruckner1, Denise Dickel, Eva Singer, Daniel F Legler.   

Abstract

Migration and homing of DCs to lymphoid organs is pivotal for inducing adaptive immunity and tolerance. DC homing depends on the chemokine receptor CCR7. However, expression of CCR7 alone is not sufficient for effective DC migration. A second signal, mediated by prostaglandin E(2) (PGE(2)), is critical for the development of a migratory DC phenotype. PGE(2) is important for inducing efficient immune responses, but, if deregulated, contributes to chronic inflammation, autoimmune diseases through Th17-cell development and tumorigenesis. In contrast, activation of liver X receptor (LXR)α has recently been shown to interfere with CCR7 expression and migration of DCs resulting in a reduced immune response. Here, we demonstrate that PGE(2) downregulates LXRα expression in human monocyte derived as well as ex vivo DCs. Moreover, PGE(2) stimulation dampens LXR activation, auto-regulation and LXR-mediated gene transcription. Consequently, we show that PGE(2) enhances CCR7 expression and migration of LXR-activated DCs. Furthermore, we provide evidence that PGE(2) signaling and LXR activation specifically elicit converse effects on CCR7 expression and DC migration. In contrast, production of MMP9, CCL4, COX-2, and IL-23 is solely regulated by PGE(2) , but not by LXR activation, offering new perspectives for therapeutic interventions.
© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22890791     DOI: 10.1002/eji.201242523

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  11 in total

1.  The transcription factor NR4A3 controls CD103+ dendritic cell migration.

Authors:  Kiwon Park; Zbigniew Mikulski; Goo-Young Seo; Aleksander Y Andreyev; Paola Marcovecchio; Amy Blatchley; Mitchell Kronenberg; Catherine C Hedrick
Journal:  J Clin Invest       Date:  2016-11-07       Impact factor: 14.808

2.  Liver X Receptor Nuclear Receptors Are Transcriptional Regulators of Dendritic Cell Chemotaxis.

Authors:  Susana Beceiro; Attila Pap; Zsolt Czimmerer; Tamer Sallam; Jose A Guillén; Germán Gallardo; Cynthia Hong; Noelia A-Gonzalez; Carlos Tabraue; Mercedes Diaz; Felix Lopez; Jonathan Matalonga; Annabel F Valledor; Pilar Dominguez; Carlos Ardavin; Cristina Delgado-Martin; Santiago Partida-Sanchez; Jose Luis Rodriguez-Fernandez; Laszlo Nagy; Peter Tontonoz; Antonio Castrillo
Journal:  Mol Cell Biol       Date:  2018-04-30       Impact factor: 4.272

3.  Cox-2 inhibition and the composition of inflammatory cell populations during early and mid-time tendon healing.

Authors:  Parmis Blomgran; Robert Blomgran; Jan Ernerudh; Per Aspenberg
Journal:  Muscles Ligaments Tendons J       Date:  2017-09-18

4.  Human Bone Marrow-Derived Mesenchymal Stromal Cells Differentially Inhibit Cytokine Production by Peripheral Blood Monocytes Subpopulations and Myeloid Dendritic Cells.

Authors:  Paula Laranjeira; Joana Gomes; Susana Pedreiro; Monia Pedrosa; Antonio Martinho; Brigida Antunes; Tania Ribeiro; Francisco Santos; Rosario Domingues; Manuel Abecasis; Helder Trindade; Artur Paiva
Journal:  Stem Cells Int       Date:  2015-04-28       Impact factor: 5.443

5.  Nuclear Receptor Nur77 Deficiency Alters Dendritic Cell Function.

Authors:  Nina Tel-Karthaus; Esther D Kers-Rebel; Maaike W Looman; Hiroshi Ichinose; Carlie J de Vries; Marleen Ansems
Journal:  Front Immunol       Date:  2018-08-03       Impact factor: 7.561

Review 6.  Immunologic Aspects of Dyslipidemia: a Critical Regulator of Adaptive Immunity and Immune Disorders.

Authors:  Daehong Kim; Hayeon Chung; Jeong-Eun Lee; Jiyeon Kim; Junseok Hwang; Yeonseok Chung
Journal:  J Lipid Atheroscler       Date:  2021-05-11

7.  CCR7 Receptor Expression in Mono-MAC-1 Cells: Modulation by Liver X Receptor α Activation and Prostaglandin E 2.

Authors:  Bérengère Tanné; Stéphane Bernier; Nancy Dumais
Journal:  Int J Inflam       Date:  2015-12-06

Review 8.  MGL Receptor and Immunity: When the Ligand Can Make the Difference.

Authors:  Ilaria Grazia Zizzari; Chiara Napoletano; Federico Battisti; Hassan Rahimi; Salvatore Caponnetto; Luca Pierelli; Marianna Nuti; Aurelia Rughetti
Journal:  J Immunol Res       Date:  2015-12-29       Impact factor: 4.818

9.  NH36 and F3 Antigen-Primed Dendritic Cells Show Preserved Migrating Capabilities and CCR7 Expression and F3 Is Effective in Immunotherapy of Visceral Leishmaniasis.

Authors:  Dirlei Nico; Fernanda Martins Almeida; Juliana Maria Motta; Fellipe Soares Dos Santos Cardoso; Celio Geraldo Freire-de-Lima; Leonardo Freire-de-Lima; Paula Melo de Luca; Ana Maria Blanco Martinez; Alexandre Morrot; Clarisa Beatriz Palatnik-de-Sousa
Journal:  Front Immunol       Date:  2018-05-07       Impact factor: 7.561

Review 10.  Microenvironmental derived factors modulating dendritic cell function and vaccine efficacy: the effect of prostanoid receptor and nuclear receptor ligands.

Authors:  Tonke K Raaijmakers; Marleen Ansems
Journal:  Cancer Immunol Immunother       Date:  2018-07-11       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.